Skip to main content
SpringerLink
Log in

Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

5-Hydroxytryptamine2C (5-HT2C) receptor agonists reduce the breakpoint in progressive ratio schedules of reinforcement, an effect that has been attributed to a decrease of the efficacy of positive reinforcers. However, a reduction of the breakpoint may also reflect motor impairment. Mathematical models can help to differentiate between these processes.

Objective

The effects of the 5-HT2C receptor agonist Ro-600175 ((αS)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine) and the non-selective 5-HT receptor agonist 1-(m-chlorophenyl)piperazine (mCPP) on rats’ performance on a progressive ratio schedule maintained by food pellet reinforcers were assessed using a model derived from Killeen’s Behav Brain Sci 17:105–172, 1994 general theory of schedule-controlled behaviour, ‘mathematical principles of reinforcement’.

Method

Rats were trained under the progressive ratio schedule, and running and overall response rates in successive ratios were analysed using the model. The effects of the agonists on estimates of the model’s parameters, and the sensitivity of these effects to selective antagonists, were examined.

Results

Ro-600175 and mCPP reduced the breakpoint. Neither agonist significantly affected a (the parameter expressing incentive value), but both agonists increased δ (the parameter expressing minimum response time). The effects of both agonists could be attenuated by the selective 5-HT2C receptor antagonist SB-242084 (6-chloro-5-methyl-N-{6-[(2-methylpyridin-3-yl)oxy]pyridin-3-yl}indoline-1-carboxamide). The effect of mCPP was not altered by isamoltane, a selective 5-HT1B receptor antagonist, or MDL-100907 ((±)2,3-dimethoxyphenyl-1-(2-(4-piperidine)methanol)), a selective 5-HT2A receptor antagonist.

Conclusions

The results are consistent with the hypothesis that the effect of the 5-HT2C receptor agonists on progressive ratio schedule performance is mediated by an impairment of motor capacity rather than by a reduction of the incentive value of the food reinforcer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Aberman JE, Ward SJ, Salamone JD (1998) Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 61:341–348

    Article  CAS  PubMed  Google Scholar 

  • Ahlenius S, Larsson K (2000) Stimulation of ejaculatory behaviour by the 5-HT1B receptor antagonist isamoltane in citalopram-pretreated male rats. Pharm Pharmacol Comm 6:317–320

    Article  CAS  Google Scholar 

  • Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296–320

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55:242–251

    Article  CAS  PubMed  Google Scholar 

  • Arnold JM, Roberts DCS (1997) A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57:441–447

    Article  CAS  PubMed  Google Scholar 

  • Baunez C, Amalric M, Robbins TW (2002) Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J Neurosci 22:562–568

    CAS  PubMed  Google Scholar 

  • Bezzina G, Body S, Cheung THC, Hampson CL, Deakin JFW, Anderson IM, Szabadi E, Bradshaw CM (2008) Effect of quinolinic acid-induced lesions of the nucleus accumbens core on performance on a progressive ratio schedule of reinforcement: implications for inter-temporal choice. Psychopharmacology 197:339–350

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bickerdike MJ (2003) 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Topics Med Chem 3:885–897

    Article  CAS  Google Scholar 

  • Bizo LA, Killeen PR (1997) Models of ratio schedule performance. J Exp Psychol Anim Behav Process 23:351–367

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bizo LA, Kettle LC, Killeen PR (2001) Rats don’t always respond faster for more food. Anim Learn Behav 29:66–78

    Article  Google Scholar 

  • Body S, Asgar K, Cheung THC, Bezzina G, Glennon JC, Bradshaw CM, Szabadi E (2006a) Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum. Behav Proc 71:258–267

    Article  CAS  Google Scholar 

  • Body S, Cheung THC, Bezzina G, Asgari K, Fone KCF, Glennon JC, Bradshaw CM, Szabadi E (2006b) Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behaviour: interaction between D1 receptors and 5-HT2A receptors. Psychopharmacology 189:331–343

    Article  CAS  PubMed  Google Scholar 

  • Body S, Cheung THC, Bezzina G, Hampson CL, Fone KCF, Bradshaw CM, Glennon JC, Szabadi E (2014) New findings on the sensitivity of free-operant timing behaviour to 5-hydroxytryptamine receptor stimulation. Timing Time Percep

  • Bradshaw CM, Killeen PR (2012) A theory of behaviour on progressive ratio schedules, with applications in behavioural pharmacology. Psychopharmacology 222:549–564

    Article  CAS  PubMed  Google Scholar 

  • Bubar MJ, Cunningham KA (2006) Serotonin (5-HT) and 5-HT receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971–1985

    Article  CAS  PubMed  Google Scholar 

  • Bubar MJ, Stutz SJ, Cunningham KA (2011) 5-HT2C Receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway. PLoS ONE 6(6):e20508

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Burbassi S, Cervo L (2008) Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats. Psychopharmacology 196:15–27

    Article  CAS  PubMed  Google Scholar 

  • Covarrubias P, Aparicio CF (2008) Effects of reinforcer quality and step size on rats’ performance under progressive ratio schedules. Behav Process 78:246–252

    Article  Google Scholar 

  • Cunningham KA, Fox RG, Anastasio NC, Bubar MJ, Stutz SJ, Moeller FG, Gilbertson SR, Rosenzweig-Lipson S (2011) Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine vs. sucrose-associated cues. Neuropharmacology 61:513–523

  • Czachowski CL, Samson HH (1999) Breakpoint determination and ethanol self-administration using an across-session progressive ratio procedure in the rat. Alcohol Clin Exp Res 23:1580–15866

  • Dalton GL, Lee MD, Kennett GA, Dourish CT, Clifton PT (2004) mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology 46:663–671

    Article  CAS  PubMed  Google Scholar 

  • De Deurwaerdere P, Chesselet MF (2000) Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats. J Neurosci 20:5170–5178

    PubMed  Google Scholar 

  • De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24:3235–3241

    Article  PubMed  Google Scholar 

  • De Deurwaerdere P, Lagiere M, Bosc M, Navailles S (2013) Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology. Exp Brain Res 230:477–511

    Article  PubMed  Google Scholar 

  • Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet J-M, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ (2008) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology 119:549–568

    Article  Google Scholar 

  • Di Giovanni G, Di Matteo V, La Grutta V, Esposito E (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111–116

    Article  PubMed  Google Scholar 

  • Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999) SB242084, a selective serotonin-2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195–1205

    Article  PubMed  Google Scholar 

  • Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin-2C receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418–429

    Article  PubMed  Google Scholar 

  • Di Matteo V, Di Giovanni G, Pierucci M, Esposito E (2008) Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Prog Brain Res 172:7–44

    Article  PubMed  Google Scholar 

  • Filip M, Bader M (2009) Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep 61:761–777

    Article  CAS  PubMed  Google Scholar 

  • Filip M, Cunningham KA (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are Under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex. J Pharm Exp Ther 306:734–743

    Article  CAS  Google Scholar 

  • Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246–1254

    Article  CAS  PubMed  Google Scholar 

  • Filip M, Alenina N, Bader M, Przegaliński E (2010) Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict Biol 15:227–249

    Article  CAS  PubMed  Google Scholar 

  • Filip M, Spampinato U, McCreary AC, Przegaliński E (2012) Pharmacological and genetic interventions in serotonin (5-HT)2C receptors to alter drug abuse and dependence processes. Brain Res 1476:132–153

    Article  CAS  PubMed  Google Scholar 

  • Fletcher PJ, Chintoh AF, Sinyard J, Higgins GA (2004) Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308–318

    Article  CAS  PubMed  Google Scholar 

  • Fletcher PJ, Sinyard J, Higgins GA (2006) The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology 187:515–525

    Article  CAS  PubMed  Google Scholar 

  • Fletcher PJ, Le AD, Higgins GA (2008) Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog Brain Res 172:361–383

    Article  CAS  PubMed  Google Scholar 

  • Fletcher PJ, Tampakeras M, Sinyard J, Slassi A, Isaac M, Higgins GA (2009) Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice. Neuropharmacology 57:259–267

    Article  CAS  PubMed  Google Scholar 

  • Fletcher PJ, Sinyard J, Higgins GA (2010) Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 97:170–178

    Article  CAS  PubMed  Google Scholar 

  • Fletcher PJ, Rizos Z, Noble K, Soko AD, Silenieks LB, Dzung Lê A, Higgins GA (2012) Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology 62:2288–2298

    Article  CAS  PubMed  Google Scholar 

  • Giorgetti M, Teccot LH (2004) Contributions of 5-HT2C receptors to multiple actions of central serotonin systems. Eur J Pharmacol 488:1–9

    Article  CAS  PubMed  Google Scholar 

  • Gleason SD, Lucaites VL, Shannon HE, Nelson DL, Leander JD (2001) m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors. Behav Pharmacol 12:613–620

    Article  CAS  PubMed  Google Scholar 

  • Gobert A, Rivet J-M, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas J-P, Cistarelli L, Melon C, Millan MJ (2000) Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205–221

    Article  CAS  PubMed  Google Scholar 

  • Gommans J, Hijzen TH, Pattij T, van der Gutgen J, Olivier B (1999) Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety. Pharmacol Biochem Behav 64:385–387

    Article  CAS  PubMed  Google Scholar 

  • Graf M, Kantor S, Anheuer ZE, Modos EA, Bagdy G (2003) m-CPP-induced self-grooming is mediated by 5-HT2C receptors. Behav Brain Res 142:175–179

    Article  CAS  PubMed  Google Scholar 

  • Graves SM, Viskniskki AA, Cunningham KA, Napier TC (2013) Serotonin(2C) receptors in the ventral pallidum regulate motor function in rats. Neuroreport 24:605–608

    Article  CAS  PubMed  Google Scholar 

  • Griffiths RR, Brady JV, Snell JD (1978) Progressive-ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine. Psychopharmacology 56:5–13

    Article  CAS  PubMed  Google Scholar 

  • Grottick AJ, Fletcher PJ, Higgins GA (2000) Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183–1191

    CAS  PubMed  Google Scholar 

  • Grottick AJ, Corrigall WA, Higgins GA (2001) Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157:292–298

    Article  CAS  PubMed  Google Scholar 

  • Halford JCG, Harrold JA, Lawton CL, Blundell JE (2005) Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr Drug Targets 6:201–213

    Article  CAS  PubMed  Google Scholar 

  • Hamik A, Peroutka SJ (1989) 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiat 25:569–575

    Article  CAS  PubMed  Google Scholar 

  • Higgins GA, Fletcher PJ (2003) Serotonin and drug reward: focus on 5-HT2C receptors. Eur J Pharmacol 480:151–162

    Article  CAS  PubMed  Google Scholar 

  • Higgins GA, Ouagazzal AM, Grottick AJ (2001) Influence of the 5-HT2C receptor antagonist SB242,084 on behaviour produced by the 5-HT2 agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine. Br J Pharmacol 133:459–466

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Higgins GA, Silenieks LB, Roβmann A, Rizos Z, Noble K, Soko AD, Fletcher PJ (2012) The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology 37:1177–1191

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Higgins GA, Silenieks LB, Lau W, de Lannoy IAM, Lee DKH, Izhakova J, Coen K, Le KD, Fletcher PJ (2013) Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles. Psychopharmacology 226:475–490

    Article  CAS  PubMed  Google Scholar 

  • Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943–944

    Article  CAS  PubMed  Google Scholar 

  • Hodos W, Kalman G (1963) Effects of increment size and reinforcer volume on progressive ratio performance. J Exp Anal Behav 6:387–392

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59–81

    CAS  PubMed  Google Scholar 

  • Invernizzi RW, Pierucci M, Calcagno E, Di Giovanni G, Di Matteo V, Benigno A, Esposito E (2007) Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144:1523–1535

    Article  CAS  PubMed  Google Scholar 

  • Katsidoni V, Apazoglou K, Panagis G (2011) Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine. Psychopharmacology 213:337–354

    Article  CAS  PubMed  Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kennett GA, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects of RO 60–0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety. Eur J Pharmacol 387:197–204

    Article  CAS  PubMed  Google Scholar 

  • Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609–620

  • Khaliq S, Irfan B, Haider S, Halleem DJ (2008) m-CPP induced hypolocomotion does not interfere in the assessment of memory functions in rats. Pak J Pharm Sci 21:139–143

    CAS  PubMed  Google Scholar 

  • Killeen PR (1994) Mathematical principles of reinforcement. Behav Brain Sci 17:105–172

    Article  Google Scholar 

  • Killeen PR, Posadas-Sanchez D, Johansen EB, Thrailkill EA (2009) Progressive ratio schedules of reinforcement. J Exp Psychol: Anim Behav Proc 35:35–50

    Google Scholar 

  • Levin ED, Johnson JE, Slade S, Wells C, Cauley M, Petro A, Rose JE (2011) Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats. J Pharmacol Exp Ther 338:890–896

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther 249:155–164

    CAS  PubMed  Google Scholar 

  • Marston OJ, Heisler LK (2009) Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes. Neuropsychopharmacology 34:252–253

    Article  CAS  PubMed  Google Scholar 

  • Martin JR, Bos M, Jenck F, Moreau J, Mutel V, Sleight AJ, Wichmann J, Andrews JS, Berendsen HH, Broekkamp CL, Ruigt GS, Köhler C, Delft AM (1998) 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913–924

    CAS  PubMed  Google Scholar 

  • Millan MJ, Dekeyne A, Gobert A (1998) Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953–955

    Article  CAS  PubMed  Google Scholar 

  • Miller KJ (2005) Serotonin 5-HT2c receptor agonists: potential for the treatment of obesity. Molec Interventions 5:282–291

    Article  CAS  Google Scholar 

  • Mosher T, Hayes D, Greenshaw A (2005) Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats. Eur J Pharmacol 515:107–116

    Article  CAS  PubMed  Google Scholar 

  • Nefs G, Pouwer F, Denollet J, Kramer H, Wijnands-van Gent CJ, Pop VJ (2012) Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia? J Psychiatr Res 46:549–554

    Article  CAS  PubMed  Google Scholar 

  • Nilsson BM (2006) 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents. J Med Chem 49:4023–4034

    Article  CAS  PubMed  Google Scholar 

  • Olarte-Sánchez CM, Valencia-Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E, Goudie AJ (2012a) A clozapine-like effect of cyproheptadine on progressive-ratio schedule performance. J Psychopharm 26:857–870

    Article  Google Scholar 

  • Olarte-Sánchez CM, Valencia-Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E (2012b) Effect of orexin-B-saporin induced lesions of the lateral hypothalamus on a progressive-ratio schedule. J Psychopharm 26:871–886

    Article  Google Scholar 

  • Olarte-Sánchez CM, Valencia-Torres L, Cassaday HJ, Bradshaw CM, Szabadi E (2013) Effects of SKF-83566 and haloperidol on performance on progressive ratio schedules maintained by sucrose and corn oil reinforcement: quantitative analysis using a new model derived from the Mathematical Principles of Reinforcement (MPR). Psychopharmacology 230:617–630

  • Papakosta V-M, Kalogerakou S, Kontis D, Anyfand E, Theochari E, Boulougouris V, Papadopoulos S, Panagis G, Tsaltas E (2013) 5-HT2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive–compulsive disorde. Behav Brain Res 243:176–183

    Article  CAS  PubMed  Google Scholar 

  • Ping-Teng C, Lee ES, Konz SA, Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Meth 66:1–11

    Article  Google Scholar 

  • Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdere P, Caccia S, Esposito E, Spampinato U (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311–324

    Article  CAS  PubMed  Google Scholar 

  • Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD (2012) Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS ONE 7(10):e47934

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Reilly MP (2003) Extending mathematical principles of reinforcement into the domain of behavioral pharmacology. Behav Proc 62:75–88

    Article  Google Scholar 

  • Rickard JF, Body S, Zhang Z, Bradshaw CM, Szabadi E (2009) Effect of reinforcer magnitude on performance maintained by progressive-ratio schedules. J Exp Anal Behav 91:75–87

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Roberts DCS, Richardson NR (1992) Self-administration of psychostimulants using progressive ratio schedules of reinforcement. In: Boulton A, Baker G, Wu PH (eds) Neuromethods., vol 24: animal models of drug addiction. New York, Humana, pp 233–269

  • Sanabria F, Acosta JI, Killeen PR, Neisewander JL, Bizo LA (2008) Modeling the effects of fluoxetine on food-reinforced behavior. Behav Pharmacol 19:61–70

    Article  CAS  PubMed  Google Scholar 

  • Schepisi C, De Carolis L, Nencini P (2013) Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behaviour. Psychopharmacology 227:55–66

    Article  CAS  PubMed  Google Scholar 

  • Shimazoe T, Nakamura S, Kobayashi K, Watanabe S, Miyasaka K, Kono K, Funakoshi A (2004) Role of 5-HT1B receptors in entrainment disorder of Otsika Long Evans Tokushima Fatty (OLETF) rats. Neuroscience 123:201–205

    Article  CAS  PubMed  Google Scholar 

  • Skjoldager P, Pierre PJ, Mittleman G (1993) Reinforcer magnitude and progressive ratio responding in the rat: effects of increased effort, prefeeding, and extinction. Learn Motiv 24:303–343

    Article  Google Scholar 

  • Stafford D, Branch MN (1998) Effects of step size and break-point criterion on progressive-ratio performance. J Exp Anal Behav 70:123–138

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Steidl O, Misane I, Koch M, Pattij T, Meyer M, Ögren SO (2007) Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology 52:949–957

    Article  Google Scholar 

  • Stubbs DA (1976) Scaling of stimulus durations by pigeons. J Exp Anal Behav 26:15–25

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tomkins DM, Joharchi N, Tampakeras M, Martin JR, Wichmann J, Higgins GA (2002) An investigation of the role of 5-HT2C receptors in modifying ethanol self-administration behaviour. Pharmacol Biochem Behav 71:735–744

    Article  CAS  PubMed  Google Scholar 

  • Valencia-Torres L, Bradshaw CM, Bouzas A, Hong E, Orduña V (2014) Effect of streptozotocin-induced diabetes on performance on a progressive ratio schedule. Psychopharmacology 231:2375–2384

    Article  CAS  PubMed  Google Scholar 

  • Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA (2008) Effects of a cannabinoid1 receptor antagonist and serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharm Exp Ther 325:567–576

    Article  CAS  Google Scholar 

  • Wolff MC, Leander JD (2000) A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon. Behav Pharmacol 11:355–364

    Article  CAS  PubMed  Google Scholar 

  • Wright FL, Rodgers RJ (2014) On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination. Psychopharmacology 231:787–800

    Article  CAS  PubMed  Google Scholar 

  • Wynne CDL, Staddon JER, Delius JD (1996) Dynamics of waiting in pigeons. J Exp Anal Behav 65:603–618

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to V.K. Bak and R.W. Langley for skilled technical assistance.

Author information

Authors and Affiliations

  1. Psychopharmacology Section, Division of Psychiatry, University of Nottingham, Medical School, Nottingham, NG7 2UH, UK

    G. Bezzina, S. Body, T. H. C. Cheung, C. L. Hampson, C. M. Bradshaw & E. Szabadi

  2. Department of Cognitive Neuroscience, Radboud University, Nijmegen Medical Centre, Nijmegen Medical Centre, Nijmegen, The Netherlands

    J. C. Glennon

Authors
  1. G. Bezzina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Body
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. H. C. Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. L. Hampson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. M. Bradshaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. C. Glennon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Szabadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. M. Bradshaw.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bezzina, G., Body, S., Cheung, T.H.C. et al. Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule. Psychopharmacology 232, 699–711 (2015). https://doi.org/10.1007/s00213-014-3700-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-014-3700-5

Keywords

Search

Navigation